![Robert Hopfner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 53 506 $ in data 30/06/2026
Robert L.
Hopfner currently serves as Director at Oculis SA and Rallybio Holdings LLC.
He is Director at Plexium, Inc. since 2021 and Independent Director at Rallybio Corp.
since 2020.
He is Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
Former roles include Director at Hyperion Therapeutics, Inc. from 2010 to 2013, Director at Oculis Holding AG, Managing Director at Bay City Capital LLC, Director at Durata Therapeutics, Inc., Director at Altheos, Inc., Independent Director at Civitas Therapeutics, Inc., Independent Director at Vaxcyte, Inc. from 2017 to 2021, Independent Director at Entasis Therapeutics, Inc., Director at Iterum Therapeutics Plc from 2017 to 2018, Director at Imara, Inc., Director at Entasis Therapeutics Holdings, Inc., Independent Director at Inozyme Pharma, Inc. from 2018 to 2025, and Associate at DuPont Pharmaceuticals Co. Education includes undergraduate and doctorate degrees from the University of Saskatchewan and an MBA from The University of Chicago Booth School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EVOMMUNE, INC. 0,01% | 31/03/2026 | 4.026 ( 0,01% ) | 53 506 $ | 30/06/2026 |
RALLYBIO CORPORATION -.--% | 19/12/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EVOMMUNE, INC. | Direttore/Membro del Consiglio | 01/07/2020 |
| RALLYBIO CORPORATION | Direttore/Membro del Consiglio | 01/03/2020 |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Direttore/Membro del Consiglio | 21/01/2021 |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Direttore/Membro del Consiglio | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Investitore di Private Equity | 01/10/2017 |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| INOZYME PHARMA, INC. | Direttore/Membro del Consiglio | 01/07/2025 |
| VAXCYTE, INC. | Direttore/Membro del Consiglio | 16/09/2021 |
| ITERUM THERAPEUTICS PLC | Direttore/Membro del Consiglio | 24/05/2018 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 21 |
|---|---|
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
Rallybio Holdings LLC
Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
